Dysregulation of N6‑methyladenosine regulators predicts poor patient survival in mantle cell lymphoma
Affiliations: Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, P.R. China, Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, P.R. China, Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P.R. China
- Published online on: August 2, 2019 https://doi.org/10.3892/ol.2019.10708
- Pages: 3682-3690
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.